Lantus Versus Humalog Mix as add-on Therapy in Type Diabetes Patients Failing Sulfonylurea and Metformin Combination Treatment

PHASE3CompletedINTERVENTIONAL

Enrollment

212

Participants

Timeline

Start Date

July 31, 2001

Primary Completion Date

December 31, 2002

Study Completion Date

December 31, 2002

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Insulin glargine

solution for subcutaneous injection

DRUG

75% insulin lispro protamine suspension and 25 % insulin lispro injection

suspension for subcutaneous injection

Trial Locations (1)

Sanofi-Aventis Administrative Office, Bridgewater